Grapheal introduces digital biosensing technology into embedded systems for on-site diagnostics and remote patient monitoring. Current applications are wound care digital assistant for improving the follow-up of difficult to heal wounds. Founded in 2019, GRAPHEAL is backed by investors that include Bpifrance and Novalis Biotechnology Incubation and is headquartered in Grenoble.